ER POSITIVE BREAST CANCER
Clinical trials for ER POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ER POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for ER POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists hunt dormant cancer cells to stop breast Cancer's return
Disease control OngoingThis study is testing a hormone therapy drug called letrozole given before surgery to post-menopausal women with early-stage, estrogen-positive breast cancer. Researchers want to understand how some cancer cells survive this treatment and stay hidden in the body, which can lead t…
Matched conditions: ER POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Trial for advanced breast cancer withdrawn before starting
Disease control TerminatedThis trial was planned to compare a newer drug (trastuzumab deruxtecan) against standard treatments for a specific type of advanced breast cancer that has spread. It aimed to see which approach was better at controlling the disease and delaying its progression. However, the trial…
Matched conditions: ER POSITIVE BREAST CANCER
Phase: PHASE3 • Sponsor: Danish Breast Cancer Cooperative Group • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New pill targets Cancer's genetic weakness in first human trial
Disease control OngoingThis is a first-in-human study to find a safe dose and see how the body processes a new oral drug called ATV-1601. It is being tested in adults with advanced solid tumors, including certain breast cancers, that have a specific genetic change called an AKT1 E17K mutation. The main…
Matched conditions: ER POSITIVE BREAST CANCER
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Blood test could signal time to switch cancer drugs before scans show progression
Disease control OngoingThis study is testing whether switching breast cancer treatment earlier, based on a blood test that detects cancer DNA, helps control the disease longer than waiting for standard scans to show it's getting worse. It involves 24 people with advanced, hormone-positive breast cancer…
Matched conditions: ER POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC